5,224 Shares in iShares U.S. Pharmaceuticals ETF $IHE Bought by Purewater Capital LLC

Purewater Capital LLC bought a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 5,224 shares of the company’s stock, valued at approximately $525,000. iShares U.S. Pharmaceuticals ETF accounts for approximately 0.4% of Purewater Capital LLC’s investment portfolio, making the stock its 24th biggest holding.

Other hedge funds have also added to or reduced their stakes in the company. Sunbelt Securities Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 14.3% during the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after acquiring an additional 120 shares during the last quarter. Root Financial Partners LLC lifted its position in iShares U.S. Pharmaceuticals ETF by 36.5% in the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after purchasing an additional 186 shares during the last quarter. Corient Private Wealth LLC lifted its position in iShares U.S. Pharmaceuticals ETF by 3.1% in the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after purchasing an additional 198 shares during the last quarter. Cornerstone Wealth Group LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 13.7% during the first quarter. Cornerstone Wealth Group LLC now owns 2,847 shares of the company’s stock valued at $246,000 after purchasing an additional 342 shares during the period. Finally, NewEdge Advisors LLC increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 45.1% in the first quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock worth $121,000 after buying an additional 434 shares during the period.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE opened at $102.51 on Monday. The business has a 50 day simple moving average of $102.47 and a two-hundred day simple moving average of $97.24. iShares U.S. Pharmaceuticals ETF has a one year low of $73.76 and a one year high of $108.66. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.